Showing results (21-30 of 237) with videos related to

Sort By:
Pageof 24
Bone Marrow Transplantation|January 25, 2018
Alloantigen expression on malignant cells and healthy host tissue influences graft-versus-tumor reactions after allogeneic hematopoietic stem cell transplantationStella Robert, Jörn C Albring, Karin Frebel, et al.
Transplantation and Cellular Therapy|April 28, 2021
Fluorodeoxyglucose F 18 for the Assessment of Acute Intestinal Graft-versus-Host Disease and Prediction of Response to Immunosuppressive TherapyWolfgang Roll, Georg Evers, Rebecca Strotmann, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|December 14, 2019
Predicted Indirectly ReCognizable HLA Epitopes (PIRCHE) Are Associated with Poorer Outcome after Single Mismatch Unrelated Donor Stem Cell Transplantation: A Study of the Cooperative Transplant Study Group (KTS) of the German Group for Bone Marrow and Stem Cell Transplantation (DAG-KBT)Francis Ayuk, Martin Bornhäuser, Matthias Stelljes, et al.
Cancer|April 13, 2007
Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)Oliver G Ottmann, Barbara Wassmann, Heike Pfeifer, et al.
The Lancet. Haematology|June 7, 2017
Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trialJürgen Finke, Claudia Schmoor, Wolfgang Andreas Bethge, et al.
Respiratory Medicine|September 5, 2012
Non-invasive ventilation in immunosuppressed patients with pneumonia and extrapulmonary sepsisPeter Razlaf, Dirk Pabst, Michael Mohr, et al.
The Lancet. Haematology|December 24, 2023
Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialDomenico Russo, Michael Schmitt, Sylvain Pilorge, et al.
BMC Cancer|September 11, 2021
<sup>18</sup>F-FDG-PET-MRI for the assessment of acute intestinal graft-versus-host-disease (GvHD)Wolfgang Roll, Philipp Schindler, Max Masthoff, et al.
Hematological Oncology|March 15, 2026
Role of Radiotherapy in the Era of Novel Immune-Based Treatment Strategies for Multiple MyelomaTom Schlusemann, Evgenii Shumilov, Gabriele Reinartz, et al.
Leukemia Research|June 16, 2017
Therapy of older persons with acute myeloid leukaemiaUtz Krug, Robert Peter Gale, Wolfgang E Berdel, et al.
Pageof 24